Natrium Chloratum Teva (Sodium Chloride)

Natrium Chloratum Teva is an electrolyte solution that addresses conditions requiring fluid and electrolyte management.

• Fluid replacement: restores intravascular volume and corrects sodium‑chloride deficits in dehydration or blood loss.
• Electrolyte replenishment: supplies essential sodium and chloride ions to maintain plasma osmolarity and acid‑base balance.
• Joint irrigation: used intra‑ or peri‑articularly to flush surgical sites and reduce debris during orthopedic procedures.

• Sodium Chloride dissociates into sodium (Na⁺) and chloride (Cl⁻) ions after intravenous or intra‑articular administration. The ions expand the extracellular fluid compartment, increasing osmotic pressure and drawing water into the vascular space, thereby correcting hyponatremia, hypochloremia, and overall fluid deficits. In joint irrigation, the isotonic solution mechanically cleans the cavity without causing cellular injury.

Adverse reactions may occur with any parenteral solution. Monitoring during and after administration is recommended.

Common Side Effects

• Local irritation at the injection site.
• Mild transient hypernatremia.
• Mild metabolic alkalosis.
• Phlebitis or vein inflammation.

Serious or Rare Side Effects

• Severe hypernatremia leading to neurological symptoms.
• Fluid overload causing pulmonary edema.
• Electrolyte imbalance with severe hypochloremia.
• Anaphylactoid reactions to preservatives (if present).

When using Natrium Chloratum Teva, clinicians should observe several safety measures.

• Assess baseline electrolyte status: obtain serum Na⁺ and Cl⁻ levels before infusion.
• Monitor infusion rate: avoid rapid bolus administration that may cause cardiac stress.
• Avoid excessive volume: watch for signs of fluid overload in patients with cardiac or renal impairment.
• Use compatible IV solutions: do not mix with drugs that may precipitate.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Sodium chloride can interact with other agents that affect fluid balance or electrolyte concentrations.

Major Interactions (Avoid)

• Hypertonic glucose solutions: concurrent use may exacerbate hypernatremia.
• Loop diuretics: can intensify sodium loss, counteracting the intended effect.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may increase risk of hyperkalemia when combined with large sodium loads.
• Corticosteroids: may alter fluid distribution, requiring closer monitoring.
• Blood products: simultaneous infusion may affect electrolyte measurements.